Provenienza dei contatti di primo grado di Soo-Yeon Jang
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Pelemed Co., Ltd.
 Pelemed Co., Ltd. Pharmaceuticals: GenericHealth Technology Pelemed Co., Ltd. is a South Korean company based in Seoul that specializes in the development of innovative anticancer drugs. Pelemed's technology platform, PeLeSeLect & AHEDD, overcomes mutation-mediated drug resistance and enables precision drug design for kinase-targeted therapies. The company's pipeline includes several drugs in various stages of development for the treatment of different types of cancer. Pelemed has received funding from the IP Voucher Funded by MSS and has a scientific advisory board that includes experts from the ASAN Medical Center Bio Core Facility. The company was founded in 2019, and its CEOs are Yong-Chul Kim and Soo-Yeon Jang.
2
| Holding Company | Pharmaceuticals: Generic | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Soo-Yeon Jang tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| KOREA UNITED PHARM INC. | Pharmaceuticals: Major | Director/Board Member | |
| Seoul National University | College/University | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Corea del Sud | 3 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Gun-Wook Kang | 3 |
| Yong-Chul Kim | 1 |
- Borsa valori
- Insiders
- Soo-Yeon Jang
- Connessioni Società
